Navigation Links
WuXi PharmaTech Honored on the Deloitte Technology Fast 500 Asia Pacific 2008 List for the Fifth Consecutive Year
Date:2/8/2009

SHANGHAI, China, Feb. 8 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, is proud to announce that it was selected for the Deloitte Technology Fast 500 Asia Pacific 2008 list for the fifth consecutive year. The Deloitte program recognizes technology companies in the Asia Pacific region that have achieved the fastest rates of annual revenue growth during the past three years. WuXi PharmaTech is one of only 13 companies to be so recognized for five years in a row and the only such company in China.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

"Achieving our place in this ranking of Asia Pacific's elite growth companies is recognition of our successful business model," commented Mr. Benson Tsang, Chief Financial Officer of WuXi PharmaTech. "Our business is built around an intense focus on meeting the needs of our biopharmaceutical and medical device partners to improve R&D productivity. We are continuing to make steady progress in expanding our service portfolio to provide a global, fully integrated, high-quality R&D service platform. Our ongoing work to begin GLP toxicology operations in Suzhou, in what will be the largest such facility in China, and to integrate WuXi operations with those of U.S.-based AppTec Laboratory Services, Inc., represent important milestones in that effort."

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTec
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. WuXi PharmaTech Appoints Stewart Hen and Ning Zhao to Its Board of Directors; Tao Lin Leaves Board
2. WuXi PharmaTech to Present at 20th Annual Piper Jaffray Healthcare Conference
3. WuXi PharmaTech Expands Collaboration for Fully Integrated Services
4. WuXi PharmaTech Announces Second Quarter 2008 Results
5. WuXi PharmaTech (NYSE: WX) Appoints Mr. Steven M. Hutchins as VP of Business Development
6. Dr. Richard M. Soll Joined WuXi PharmaTech (NYSE: WX) as VP of Medicinal Chemistry
7. WuXi PharmaTech 2007 Annual Report Available Online
8. The First QPatch HT in China Placed in WuXi PharmaTech (NYSE: WX)
9. Stanford Professor Barry M. Trost Visits WuXi PharmaTech and Gives Two Seminars
10. WuXi PharmaTech Announces Postponement of Proposed Follow-on Offering
11. Princeton Professor David W. C. MacMillan Lectured WuXi PharmaTech Scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort located ... the number one best large hotel for families in the ... their annual Travelers’ Choice Awards. , TripAdvisor represents the ... home to millions of unbiased and honest traveler reviews. The ...
(Date:1/22/2015)... 23, 2015 Angelweddingdress is a famous wedding ... its customers to follow it on Facebook, Twitter, and Pinterest. ... Day gift. Angelweddingdress draws a lottery every week. , Moreover, ... Feb. 28, 2015. Click Angelweddingdress homepage for more ...
(Date:1/22/2015)... A new white paper by The Beryl ... the long-term care environment as well as provides recommendations ... paper, “The Power of Person-Centeredness in Long-Term Care: A ... the patient, resident and family experience in long-term care ...
(Date:1/22/2015)... January 22, 2015 Joan Lunden, award-winning ... speaker at the upcoming 32nd Annual Miami Breast ... Physicians’ Education Resource®, LLC (PER®) , shares that “a ... gone undetected if she had not followed up her ...
(Date:1/22/2015)... 22, 2015 Four years since the release of ... coincided with the marriage of Avasa & Matthew Love – the ... is scheduled for release through White Swan Records on February 24, ... is a sacred path available to all of us to walk ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... 15 HLTH Corporation (Nasdaq: HLTH ) and its ... ), today announced that they will release their respective financial results ... pm (ET) on Tuesday, May 5, 2009. The Companies will host ... discuss those results. Investors can access the call via webcast ...
... a relationship of hepatitis C (HCV) infection with type ... unclear. , A research article to be published on ... Gastroenterology addresses this question. The research team led ... of the People,s Liberation Army 161 Hospital in Wuhan ...
... pick the tunes, study suggests , , WEDNESDAY, April 15 (HealthDay ... to plug in that iPod or pop in a CD ... reduced their heart rates, breathing rate and blood pressure just ... previous studies found. , The report, published in the latest ...
... 15 Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), ... of novel antibiotics for the treatment of antibiotic-resistant infections, ... in China. The State Intellectual Property Office of ... Number ZL 2004 8 0021883.9 to Rib-X. This ...
... Further Reduces 2009 Operating Expenses to Address Continued ... Results on Tuesday, May 5 WESTFORD, Mass., ... (Nasdaq: CYNO ), a leading ... light-based aesthetic treatment systems, today announced preliminary, unaudited ...
... Efficacy than Levitra for Patients with Hypertension Priced at ... 50 Percent Patient Share in the U.S., According to ... Decision Resources, one of the world,s leading research ... that although surveyed primary care physicians (PCPs) are generally ...
Cached Medicine News:Health News:HLTH and WebMD Announce First Quarter Earnings Release Date and Conference Call 2Health News:Do patients at risk for B-cell malignancy need antiviral treatment? 2Health News:Soothing Songs Please the Heart 2Health News:Rib-X Granted Key Antibiotic Patent in China 2Health News:Cynosure Announces Preliminary Financial Results for the First Quarter of 2009 2Health News:Cynosure Announces Preliminary Financial Results for the First Quarter of 2009 3Health News:Cynosure Announces Preliminary Financial Results for the First Quarter of 2009 4Health News:For Erectile Dysfunction, Physicians Indicate That Opportunity Exists for Emerging Therapies with Improved Efficacy in Difficult-to-Treat Patient Subpopulations 2Health News:For Erectile Dysfunction, Physicians Indicate That Opportunity Exists for Emerging Therapies with Improved Efficacy in Difficult-to-Treat Patient Subpopulations 3
(Date:1/23/2015)... and DUBLIN , Jan. 23, 2015  Immune ... KRS Global Biotechnology, Inc. for the compounding, packaging and distributing ... shipment in the United States . ... Facility capable of compounding naltrexone tablets in various strengths for ...
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: ... Phase I trial of Lixte,s lead compound, LB‑100, is being ... John S. Kovach , M.D., the founder and ... to be completed at a single site. Accrual of patients, ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... Pharmaceutical Major, Lupin Ltd. announced today the acquisition of ... mg). Lupin acquired the product from Oscient Pharmaceuticals on ... Court. Antara recorded net sales of US $ 70 ... $ 38.61 million for the product and related assets inclusive ...
... , SAN FRANCISCO, Sept. 24 ... that ticagrelor (BRILINTA((TM))) provided greater reduction of cardiovascular (CV) events ... (9.02% vs. 10.65%, p=0.0025 a 16% Relative Risk Reduction ) ... (either PCI or CABG).* Although patients undergoing invasive procedures ...
Cached Medicine Technology:Lupin Expands Branded Play 2Lupin Expands Branded Play 3Ticagrelor Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial 2Ticagrelor Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial 3Ticagrelor Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial 4
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Ultra Thin Sheet. Medpor Sheets are commonly used for orbital floor reconstruction and other craniofacial applications....
... Designed for precise punching of ... is designed for use with disposable ... block aids in centration of the ... the block is held centrally under ...
Broad Tip and Ultra-Micro Needle Tip, sterile, 10 per Box, 10 Boxes per Case...
Medicine Products: